Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells

European Journal of Pharmacology

Volumn 557, Issue 1, 2007, Pages 9-19

  Hashemi, Mohammad ^a   Ghavami, Saeid ^a,b   Eshraghi, Mehdi ^b   Booy, Evan P ^b   Los, Marek ^b,c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Apoptosis; Breast cancer; Caspase; Cu Zn dismutase; Diethylenetriaminepentacetic acid; N,N,N ,N tetrakis(2 pyridylmethyl)ethylenediamine

Indexed keywords

CASPASE 3; CASPASE 9; CHELATING AGENT; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; PENTETIC ACID; TRANSCRIPTION FACTOR; ZINC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL MEMBRANE; CHELATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; HORMONE RELEASE; HUMAN; HUMAN CELL; IMMUNITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METABOLISM;

ACETYLCYSTEINE; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; CHELATING AGENTS; CYTOCHROMES C; ETHYLENEDIAMINES; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; PENTETIC ACID; RECEPTORS, ESTROGEN; ZINC;

EID: 33846396238     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.010     Document Type: Article

References (71)

1. Adler M., Shafer H., Hamilton T., and Petrali J.P. Cytotoxic actions of the heavy metal chelator TPEN on NG108-15 neuroblastoma-glioma cells. Neurotoxicology 20 (1999) 571-582
2. Ahn Y.H., Kim Y.H., Hong S.H., and Koh J.Y. Depletion of intracellular zinc induces protein synthesis-dependent neuronal apoptosis in mouse cortical culture. Exp. Neurol. 154 (1998) 47-56
3. Bagchi D., Vuchetich P.J., Bagchi M., Tran M.X., Krohn R.L., Ray S.D., and Stohs S.J. Protective effects of zinc salts on DTPA-induced hepatic and brain lipid peroxidation, glutathione depletion, DNA damage and peritoneal macrophage activation in mice. Gen. Pharmacol. 30 (1998) 43-50
4. Banerji S., and Los M. Important differences between topoisomerase-I and II targeting agents. Cancer Biol. Ther. 5 (2006) 965-966
5. Barczyk K., Kreuter M., Pryjma J., Booy E.P., Maddika S., Ghavami S., Berdel W.E., Roth J., and Los M. Serum cytochrome c indicates in vivo-apoptosis and it can serve as a prognostic marker during cancer therapy. Int. J. Cancer. 114 (2005) 167-173
6. Behroozi S.J., Kim W., Dannaldson J., and Gates K.S. 1,2-dithiolan-3-one 1-oxides: a class of thiol-activated DNA-cleaving agents that are structurally related to the natural product leinamycin. Biochemistry 35 (1996) 1768-1774
7. Berg J.M., and Shi Y. The galvanization of biology: a growing apprecia-tion for the roles of zinc. Science 271 (1996) 1081-1085
8. Bergan T., Klaveness J., and Aasen A.J. Chelating agents. Chemotherapy 47 (2001) 10-14
9. Booy E.P., Kadkhoda K., Johar D., Bay G.H., and Los M. The immune system, involvement in neurodegenerative diseases, ageing and cancer. Curr. Med. Chem. Anti-Inflamm. Anti-Allerg. Agents 4 (2005) 349-353
10. Bradford M.M. A rapid and sensitive method for the quantities of microgram of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. Brouckaert G., Kalai M., Saelens X., and Vandenabeele P. Apoptotic pathways and their regulation. In: Los M., and Gibson S.B. (Eds). Apoptotic Pathways as Target for Novel Therapies in Cancer and Other Diseases (2005), Springer Academic Press, New York
12. Burke J.P., and Fenton M.R. Effect of a zinc-deficient diet on lipid peroxidation in liver and tumor subcellular membranes. Proc. Soc. Exp. Biol. Med. 179 (1985) 187-191
13. Carter J.E., Truong-Tran A.Q., Grosser D., Ho L., Ruffin R.E., and Zalewski P.D. Involvement of redox events in caspase activation in zinc-depleted airway epithelial cells. Biochem. Biophys. Res. Commun. 297 (2002) 1062-1070
14. Chai F., Truong-Tran A.Q., Ho L.H., and Zalewski P.D. Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: a review. Immunol. Cell Biol. 77 (1999) 272-278
15. Elmes M.E. Apoptosis in the small intestine of zinc-deficient and fasted rats. J. Pathol. 123 (1977) 219-223
16. Fukamachi Y., Karasaki Y., Sugiura T., Itoh H., Abe T., Yamamura K., and Higashi K. Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio. Biochem. Biophys. Res. Commun. 246 (1998) 364-369
17. Ghavami S., Kerkhoff C., Los M., Hashemi M., Sorg C., and Karami-Tehrani F. Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol. 76 (2004) 169-175
18. Ghavami S., Barczyk K., Maddika S., Vogl T., Steinmüller L., Pour-Jafari H., Evans J.A., and Los M. Monitoring of programmed cell death in vivo and in vitro, - new and old methods of cancer therapy assessment. In: Los M., and Gibson S.B. (Eds). Apoptotic Pathways as Target for Novel Therapies in Cancer and Other Diseases (2005), Springer Science, New York 323-341
19. Ghavami S., Hashemi M., Kadkhoda K., Alavian S.M., Bay G.H., and Los M. Apoptosis in liver diseases - detection and therapeutic applications. Med. Sci. Monit. 11 (2005) RA337-RA345
20. Hashemi M., and Kroczak T.J. Apoptosis and autoimmune disease. Curr. Med. Chem. Anti-Inflamm. Anti-Allerg. Agents 4 (2005) 429-437
21. Hashemi M., Karami-Tehrani F., Ghavami S., Maddika S., and Los M. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and negative human breast cancer cells via the intrinsic pathway. Cell Prolif. 38 (2005) 269-285
22. Hauff K., Zamzow C., Law W.J., de Melo J., Kennedy K., and Los M. Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous system. Arch. Immunol. Ther. Exp. 53 (2005) 308-320
23. Heximer S.P., and Forsdyke D.R. A human putative lymphocyte G0/G1switch gene homologous to a rodent gene encoding a zinc-binding potential transcription factor. DNA Cell Biol. 12 (1993) 73-88
24. Ho E., Courtemanche C., and Ames B.N. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J. Nutr. 133 (2003) 2543-2548
25. Huang E.P. Metal ions and synaptic transmission: think zinc. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13386-13387
26. Hyun H.J., Sohn J., Ahn Y.H., Shin H.C., Koh J.Y., and Yoon Y.H. Depletion of intracellular zinc induces macromolecule synthesis and caspase-dependent apoptosis of cultured retinal cells. Brain Res. 869 (2000) 39-48
27. 2+. Lab. Invest. 73 (1995) 111-117
28. Johnson V.L., Ko S.C., Holmstrom T.H., Eriksson J.E., and Chow S.C. Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis. J. Cell Sci. 113 Pt 17 (2000) 2941-2953
29. Kennedy C.J., Rakoczy P.E., Robertson T.A., Papadimitriou J.M., and Constable I.J. Kinetic studies on phagocytosis and lysosomal digestion of rod outer segments by human retinal pigment epithelial cells in vitro. Exp. Cell Res. 210 (1994) 209-214
30. Klug A. Zinc finger peptides for the regulation of gene expression. J. Mol. Biol. 293 (1999) 215-218
31. Kolenko V.M., Uzzo R.G., Dulin N., Hauzman E., Bukowski R., and Finke J.H. Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes. Apoptosis 6 (2001) 419-429
32. Kottke T.J., Blajeski A.L., Meng X.W., Svingen P.A., Ruchaud S., Mesner P.W., Boerner S.A.J., Samejima K., Henriquez V., Chilcote T.J., Lord J., Salmon M., Earnshaw W.C., and Kaufmann S.H. Lack of correlation between caspase activation and caspase activity assays in paclitaxeltreated MCF-7 breast cancer cells. J. Biol. Chem. 277 (2002) 804-815
33. Kroczak T.J., Baran J., Pryjma J.S.,M., Rashedi I., Hernandez E., Alberti E.M.,S., and Los M. The emerging importance of DNA mapping and other comprehensive screening techniques as tools to identify new drug targets and as a mean of (cancer) therapy personalization. Expert Opin. Ther. Targets 10 2 (2006) 289-302
34. Krzemieniecki K., Szpyt E., Rashedi I., Gawron K., and Los M. Targeting of solid tumors and blood malignancies by antibody-based therapies - EGFR-pathway as an example. Centr. Eur. J. Biol. 1 (2006) 167-182
35. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
36. Los M., Herr I., Friesen C., Fulda S., Schulze-Osthoff K., and Debatin K.M. Cross-resistance of CD95-and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood 90 (1997) 3118-3129
37. Los M., Wesselborg S., and Schulze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10 (1999) 629-639
38. Maddika S., Booy E.P., Johar D., Gibson S.B., Ghavami S., and Los M. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell death mediators by a Nur77-dependent pathway. J. Cell Sci. 118 (2005) 4485-4493
39. Mares-Perlman J.A., Klein R., Klein B.E., Greger J.L., Brady W.E., Palta M., and Ritter L.L. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch. Ophthalmol. 114 (1996) 991-997
40. Marini M., Frabetti F., Canaider S., Dini L., Falcieri E., and Poirier G.G. Modulation of caspase-3 activity by zinc ions and by the cell redox state. Exp. Cell Res. 266 (2001) 323-332
41. Martin S.J., Mazdai G., Strain J.J., Cotter T.G., and Hannigan B.M. Programmed cell death (apoptosis) in lymphoid and myeloid cell lines during zinc deficiency. Clin. Exp. Immunol. 83 (1991) 338-343
42. McCabe Jr. M.J., Jiang S.A., and Orrenius S. Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab. Invest. 69 (1993) 101-110
43. McClain C.J., Kasarskis Jr. E.J., and Allen J.J. Functional consequences of zinc deficiency. Prog. Food Nutr. Sci. 9 (1985) 185-226
44. Mendoza F.J., Espino P., Cann C.L., Bristow N., McCrea K., and Los M. Anti-tumor chemotherapy utilizing peptide-based approaches - apoptotic pathways, kinases and proteasome as targets. Arch. Immunol. Ther. Exp. 53 (2005) 47-60
45. Mignotte B., and Vayssiere J.L. Mitochondria and apoptosis. Eur. J. Biochem. 252 (1998) 1-15
46. Moss M.L., and Bartsch J.W. Therapeutic benefits from targeting of ADAM family members. Biochemistry 43 (2004) 7227-7235
47. Nagano T., Hirano T., and Hirobe M. Superoxide dismutase mimics based on iron in vivo. J. Biol. Chem. 264 (1989) 9243-9249
48. Ostrowski K., and Kinsner A. Inhibition of angiogenesis in the treatment of tumors. Arch. Immunol. Ther. Exp. 49 (2001) 27-31
49. Pan G., Humke E.W., and Dixit V.M. Activation of caspases triggered by cytochrome c in vitro. FEBS Lett. 426 (1998) 151-154
50. Patricia I.O., Michael S., Paola C.Z., and Carl L.K. Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic. Biol. Med. 28 (2000) 1091-1099
51. Perry D.K., Smyth M.J., Stennicke H.R., Salvesen G.S., Duriez P., Poirier G.G., and Hannun Y.A. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272 (1997) 18530-18533
52. Philchenkov A., Zavelevich M., Kroczak T.J., and Los M. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp. Oncol. 26 (2004) 82-97
53. Pour-Jafari H., Ghavami S., and Maddika S. Mitochondrial physiology and toxicity (mitotoxicity); importance for cancer, programmed cell death and the immune system. Curr. Med. Chem. Anti-Inflamm. Anti-Allerg. Agents 4 (2005) 439-451
54. Prasad A.S. Laboratory diagnosis of zinc deficiency. J. Am. Coll. Nutr. 4 (1985) 591-598
55. Prasad A.S. Discovery of human zinc deficiency and studies in an experimental human model. Am. J. Clin. Nutr. 53 (1991) 403-412
56. Rudolf E., and Cervinka M. Depletion of endogenous zinc stores induces oxidative stress and cell death in human melanoma cells. Acta Medica (Hradec Kralove) 47 (2004) 91-96
57. 2+ pools. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6157-6162
58. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., and Martin S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, 3, 6, 7, 8, and 10 in a caspase-9-dependent manner. J. Cell Biol. 144 (1999) 281-292
59. Strasser A., O'Connor L., and Dixit V.M. Apoptosis signaling. Annu. Rev. Biochem. 69 (2000) 217-245
60. Sukegawa J., and Blobel G. A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm. Cell 72 (1993) 29-38
61. Tang Z.L., Wasserloos K., St Croix C.M., and Pitt B.R. Role of zinc in pulmonary endothelial cell response to oxidative stress. Am. J. Physiol., Lung Cell. Mol. Physiol. 281 (2001) L243-L249
62. Tjen W.W., Haase H., Biagioli, and Beyersmann M.D. Induction of apoptosis in mammalian cells by cadmium and zinc. Environ. Health Perspect. 110 (2002) 865-867
63. Treves S., Trentini P.L., Ascanelli M., Bucci G., and Di Virgilio F. Apoptosis is dependent on intracellular zinc and independent of intracellular calcium in lymphocytes. Exp. Cell Res. 211 (1994) 339-343
64. Truong-Tran A.Q., Ho L.H., Chai F., and Zalewski P.D. Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J. Nutr. 130 (2000) 1459S-1466S
65. Truong-Tran A.Q., Ruffin R.E., and Zalewski P.D. Visualization of labile zinc and its role in apoptosis of primary airway epithelial cells and cell lines. Am. J. Physiol., Lung Cell. Mol. Physiol. 279 (2000) L1172-L1183
66. Vallee B.L., and Falchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 73 (1993) 79-118
67. Virgili F., Canali R., Figus E., Vignolini F., Nobili F., and Mengheri E. Intestinal damage induced by zinc deficiency is associated with enhanced Cu/Zn (II) superoxide dismutase activity in rats: effect of dexamethasone or thyroxine treatment. Free Radic. Biol. Med. 26 (1999) 1194-1201
68. Wang X., Fosmire G.J., Gay C.V., and Leach Jr. R.M. Short-term zinc deficiency inhibits chondrocyte proliferation and induces cell apoptosis in the epiphyseal growth plate of young chickens. J. Nutr. 132 (2002) 665-673
69. Yui S., Nakatani Y., Hunter M.J., Chazin W.J., and Yamazaki M. Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosis-inducing activity. Mediat. Inflamm. 11 (2002) 165-172
70. Zalewski P.D., Forbes I.J., and Betts W.H. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem. J. 296 Pt 2 (1993) 403-408
71. Zou H., Henzel W.J., Liu X., Lutschg A., and Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 (1997) 405-413